09:04 AM EDT, 06/27/2024 (MT Newswires) -- Natera ( NTRA ) said Thursday it is launching a phase 2 single-arm gastroesophageal cancer trial using Signatera, its tumor-informed molecular residual disease, MRD, test. The study will evaluate the efficacy of trastuzumab deruxtecan in gastroesophageal adenocarcinoma patients in the adjuvant setting, Natera ( NTRA ) said. The company said Signatera will be...

09:03 AM EDT, 06/27/2024 (MT Newswires) -- Kala Bio ( KALA ) said Thursday it has signed a securities purchase agreement with a group of institutional investors to sell common stock and series H convertible non-redeemable preferred shares in a private placement for gross proceeds of about $12.5 million. Under the terms, the company will sell about 1.2 million shares...

09:04 AM EDT, 06/27/2024 (MT Newswires) -- Kane Biotech ( KNBIF ) said Thursday that it has made its first commercial-scale sale of revyve antimicrobial wound gel product to ProgenaCare Global. Kane said it has now completely fulfilled its obligation related to the US$500,000 initial manufacturing scale up fee that it received upon signing an exclusive distribution agreement for the...

STOCKHOLM (Reuters) - H&M plans to offer more discounted fashions in the second half of this year as it tries to win back customers from the likes of Zara owner Inditex and Shein. H&M has over the past year or so said it was prioritising profitability over sales volumes in order to reach a 10% operating margin goal, one it...